Serum uromodulin is associated with the severity of clinicopathological findings in ANCA-associated glomerulonephritis

PLoS One. 2019 Nov 14;14(11):e0224690. doi: 10.1371/journal.pone.0224690. eCollection 2019.

Abstract

Background: Uromodulin (UMOD), also known as Tamm-Horsfall protein, is a kidney-specific protein expressed by epithelial cells lining the thick ascending limb of the loop of Henle. In the current study, we aimed to clarify the clinical significance of UMOD in ANCA-associated glomerulonephritis (AAG).

Materials and methods: Sixty-one biopsy-proven AAG patients were included in this study. UMOD was measured using ELISA. The relationships between serum UMOD (sUMOD) levels and various clinicopathological findings were evaluated.

Results: AAG was classified into four categories (focal, crescentic, mixed, and sclerotic). In addition, tubulointerstitial lesions were classified as mild, moderate, and severe. The levels of sUMOD and urinary UMOD (uUMOD) were correlated with each other. A negative correlation between sUMOD levels and serum Cr levels, and positive correlation between sUMOD levels and eGFR were found. Patients in the high sUMOD group were associated with low serum Cr levels, focal classification, and mild tubulointerstitial injury compared to the low sUMOD group. Comparing the characteristics among histopathological classes, patients in the focal class had the best renal function and the highest levels of uUMOD/Cr and sUMOD. The focal class had significantly better renal survival compared with the severe histopathological classes (crescentic, mixed, and sclerotic). In univariate logistic regression analyses, prognostic factors for severe histopathological classes were low uUMOD/Cr, high serum Cr, and low sUMOD. Multivariate analyses revealed that low sUMOD predicted severe histopathological classes independent of serum Cr. The mean levels of sUMOD were significantly different between the focal class and severe histopathological classes, with a sensitivity of 70.6% and specificity of 90.0% (cut-off 143 ng/ml, AUC 0.80) by ROC curves.

Conclusion: Low sUMOD levels were associated with severe clinicopathological findings and might be considered as a risk factor for end stage renal disease in AAG.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Antibodies, Antineutrophil Cytoplasmic*
  • Female
  • Glomerular Filtration Rate
  • Glomerulonephritis* / blood
  • Glomerulonephritis* / pathology
  • Glomerulonephritis* / urine
  • Humans
  • Kidney / metabolism
  • Kidney / pathology
  • Kidney Failure, Chronic* / blood
  • Kidney Failure, Chronic* / pathology
  • Kidney Failure, Chronic* / urine
  • Male
  • Middle Aged
  • Risk Factors
  • Uromodulin* / blood
  • Uromodulin* / urine

Substances

  • Antibodies, Antineutrophil Cytoplasmic
  • UMOD protein, human
  • Uromodulin

Grants and funding

This work was supported by a Grant-in-Aid for Scientific Research (KAKENHI) (C) from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT), Grant Number JP15K09276 (to M. I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.